Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
about
Neuromuscular paralysis for newborn infants receiving mechanical ventilationComparison of the variability of the onset and recovery from neuromuscular blockade with cisatracurium versus rocuronium in elderly patients under total intravenous anesthesia.Sugammadex: a novel approach to reversal of neuromuscular blockade.Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Diverse range of fixed positional deformities and bone growth restraint provoked by flaccid paralysis in embryonic chicks.
P2860
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
@ast
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
@en
type
label
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
@ast
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
@en
prefLabel
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
@ast
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
@en
P1476
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
@en
P2093
D P Atherton
J M Hunter
P304
P356
10.2165/00003088-199936030-00001
P577
1999-03-01T00:00:00Z
P6179
1003877603